Harmony Biosciences Holdings, Inc. (HRMY): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

58.54M
Year ended 2025-12-31
-1.4%
3-year compound annual growth
+17.8%
5-year compound annual growth
61.10M2019-12-31: 7.78M2020-12-31: 25.77M2021-12-31: 59.21M2022-12-31: 61.10M2023-12-31: 60.37M2024-12-31: 57.87M2025-12-31: 58.54M58.54M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3158.54M+1.2%2026-02-24, From 2025-01-01
2024-12-3157.87M-4.1%2026-02-24, From 2024-01-01
2023-12-3160.37M-1.2%2026-02-24, From 2023-01-01
2022-12-3161.10M+3.2%2025-02-25, From 2022-01-01
2021-12-3159.21M+129.7%2024-02-22, From 2021-01-01
2020-12-3125.77M+231.4%2023-02-21, From 2020-01-01
2019-12-317.78Mn/a2022-02-28, From 2019-01-01